Kathryn M. Frietze received a B.S. degree in Biological Sciences (2004) from Central Washington University. She earned her PhD in Biomedical Sciences (2010) from University of New Mexico, along with a Graduate Certificate in University Science Teaching. Following her PhD, she completed a postdoctoral fellowship at University of New Mexico.

Personal Statement

More information on Dr. Frietze's research and laboratory can be found at

Areas of Specialty

Antibody responses
Chlamydia trachomatis
Opioid vaccines
Dengue virus

Achievements & Awards

KL2 Scholar, April 2018 - present
R21 AI148836, May 2020 - April 2022
R01 AI166360




  • English

Research and Scholarship

Dr. Frietze's research investigates the specificity of antibody responses to infectious disease and cancer, and translates this information into new vaccines and therapeutics. She has projects investigating Chlamydia trachomatis, opioid vaccines, and dengue virus.

Collar AL, Linville AC, Core SB, and Frietze KM. Epitope-Based Vaccines against Chlamydia trachomatis Major Outer Membrane Protein Variable Domain 4 Elicit Protection in Mice. Vaccines. 2022 May 30;10(6):875. doi: 10.3390/vaccines10060875. PMID: 35746483; PMCID: PMC9227494.

Warner NL, Linville AC, Core SB, Moreno B, Pascale JM, Peabody DS, Chackerian B, Frietze KM. Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum. Viruses. 2020 Sep 30;12(10):1114. doi: 10.3390/v12101114. PMID: 33008118; PMCID: PMC7600589.

Collar AL, Linville AC, Core SB, Wheeler CM, Geisler WM, Peabody DS, Chackerian B, Frietze KM. Antibodies to Variable Domain 4 Linear Epitopes of the Chlamydia trachomatis Major Outer Membrane Protein Are Not Associated with Chlamydia Resolution or Reinfection in Women. mSphere. 2020 Sep 23;5(5):e00654-20. doi: 10.1128/mSphere.00654-20. PMID: 32968007; PMCID: PMC7568647.

Frietze KM, Pascale JM, Moreno B, Chackerian B, Peabody DS. Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses. PLoS One. 2017 Feb 2;12(2):e0171511. doi: 10.1371/journal.pone.0171511. PMID: 28152075; PMCID: PMC5289605.

Frietze KM, Roden RB, Lee JH, Shi Y, Peabody DS, Chackerian B. Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence-Coupled Biopanning Platform. Cancer Immunol Res. 2016 Feb;4(2):157-64. doi: 10.1158/2326-6066.CIR-15-0165. Epub 2015 Nov 20. PMID: 26589767; PMCID: PMC4740227.